Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1991 4
1993 4
1996 3
1997 4
1998 6
1999 2
2000 4
2001 3
2002 3
2003 8
2004 10
2005 18
2006 11
2007 8
2008 11
2009 5
2010 4
2011 8
2012 4
2013 5
2014 4
2015 2
2016 6
2017 8
2018 7
2019 12
2020 16
2021 14
2022 14
2023 18
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.
Brown DM, Emanuelli A, Bandello F, Barranco JJE, Figueira J, Souied E, Wolf S, Gupta V, Ngah NF, Liew G, Tuli R, Tadayoni R, Dhoot D, Wang L, Bouillaud E, Wang Y, Kovacic L, Guerard N, Garweg JG. Brown DM, et al. Among authors: garweg jg. Am J Ophthalmol. 2022 Jun;238:157-172. doi: 10.1016/j.ajo.2022.01.004. Epub 2022 Jan 14. Am J Ophthalmol. 2022. PMID: 35038415 Free article. Clinical Trial.
HIV-induced Retinitis.
Wons J, Kempen J, Garweg JG. Wons J, et al. Among authors: garweg jg. Ocul Immunol Inflamm. 2020 Nov 16;28(8):1259-1268. doi: 10.1080/09273948.2020.1808225. Epub 2020 Sep 23. Ocul Immunol Inflamm. 2020. PMID: 32966142 Review.
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema.
Wykoff CC, Garweg JG, Regillo C, Souied E, Wolf S, Dhoot DS, Agostini HT, Chang A, Laude A, Wachtlin J, Kovacic L, Wang L, Wang Y, Bouillaud E, Brown DM. Wykoff CC, et al. Among authors: garweg jg. Am J Ophthalmol. 2024 Apr;260:70-83. doi: 10.1016/j.ajo.2023.07.012. Epub 2023 Jul 15. Am J Ophthalmol. 2024. PMID: 37460036 Free article. Clinical Trial.
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
Macular Edema in Childhood Uveitis.
Garweg JG. Garweg JG. Klin Monbl Augenheilkd. 2018 Apr;235(4):373-376. doi: 10.1055/s-0043-123650. Epub 2018 Feb 16. Klin Monbl Augenheilkd. 2018. PMID: 29452454 Review. English.
Ocular Toxoplasmosis: an Update.
Garweg JG. Garweg JG. Klin Monbl Augenheilkd. 2016 Apr;233(4):534-9. doi: 10.1055/s-0041-111821. Epub 2016 Apr 26. Klin Monbl Augenheilkd. 2016. PMID: 27116531 Review. English.
[Treatment of ocular tuberculosis-an update].
Brönnimann LC, Zimmerli S, Garweg JG. Brönnimann LC, et al. Among authors: garweg jg. Ophthalmologe. 2020 Nov;117(11):1080-1086. doi: 10.1007/s00347-020-01099-1. Ophthalmologe. 2020. PMID: 32296921 Free article. Review. German.
Reply.
Garweg JG, Deiss M, Pfister IB, Gerhardt C. Garweg JG, et al. Retina. 2020 Feb;40(2):e8-e10. doi: 10.1097/IAE.0000000000002741. Retina. 2020. PMID: 31972815 No abstract available.
Reply.
Garweg JG, Deiss M, Pfister IB, Gerhardt C. Garweg JG, et al. Retina. 2020 Feb;40(2):e6-e7. doi: 10.1097/IAE.0000000000002740. Retina. 2020. PMID: 31972813 No abstract available.
215 results